Login


TI Ref No : 511896436
Description : Conclusion Of Non-exclusive Discount Agreements Pursuant To Section 130a Paragraph 8/130c Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Peginterferon Beta-1a (l03ab13) Within The Framework Of A So-called Open-house Model.
Date : 2024-12-14
Deadline : 2026-11-30
Document Type : Tenders
View Details
Whats app